Inhibitors of protein arginine deiminase 1 and methods of preparation and use thereof

US12448358B2 · US · B2

Patent metadata
FieldValue
Publication numberUS-12448358-B2
Application numberUS-202017622200-A
CountryUS
Kind codeB2
Filing dateJun 26, 2020
Priority dateJul 3, 2019
Publication dateOct 21, 2025
Grant dateOct 21, 2025

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

The invention provides novel inhibitors or inactivators of protein arginine deiminase 1, pharmaceutical compositions and methods of use thereof. The invention also relates to molecular probes based on such compounds and methods of use thereof.

First claim

Opening claim text (preview).

What is claimed is: 1. A compound having the structural formula (I), wherein each of R a and R b is H or D; X is a halogen atom; R 2 is selected from the group consisting of: H, OH or OCH 3 ; R 4 is selected from the group consisting of: H, halogen, ethynyl (HC≡C—) each of R 3 and R 5 is I; R 6 is H or R; and each R is independently a C 1-6 alkyl, or a pharmaceutically acceptable salt thereof. 2. The compound of claim 1 , wherein each of R a and R b is H. 3. The compound of claim 1 , wherein X is F. 4. The compound of claim 1 , wherein X is Cl. 5. The compound of claim 1 , wherein R 2 is OH. 6. The compound of claim 5 , wherein R 4 is H. 7. The compound of claim 6 , wherein R 6 is H. 8. The compound of claim 1 , wherein R 4 is a halogen atom. 9. The compound of claim 1 , in the form of a salt. 10. A pharmaceutical composition comprising a compound of claim 1 . 11. A unit dosage form comprising a pharmaceutical composition according to claim 10 . 12. A method for inhibiting or inactivating protein arginine deiminase 1 (PAD1), comprising administering to a subject in need thereof a pharmaceutical composition of claim 10 .

Assignees

Inventors

Classifications

  • Drugs for immunological or allergic disorders · CPC title

  • Antineoplastic agents · CPC title

  • Feminine contraceptives · CPC title

  • C07D235/16Primary

    Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals · CPC title

  • C07D235/14Primary

    Radicals substituted by nitrogen atoms (by nitro radicals C07D235/10) · CPC title

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US12448358B2 cover?
The invention provides novel inhibitors or inactivators of protein arginine deiminase 1, pharmaceutical compositions and methods of use thereof. The invention also relates to molecular probes based on such compounds and methods of use thereof.
Who is the assignee on this patent?
Univ Massachusetts
What technology area does this patent fall under?
Primary CPC classification C07D235/16. Mapped technology areas include Chemistry & Metallurgy.
When was this patent published?
Publication date Tue Oct 21 2025 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 1 related publication on this page (citations in our corpus or others sharing the same primary CPC).